|
1
|
Brodeur GM: Neuroblastoma: Biological
insights into a clinical enigma. Nat Rev Cancer. 3:203–216. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Maris JM, Hogarty MD, Bagatell R and Cohn
SL: Neuroblastoma. Lancet. 369:2106–2120. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Garaventa A: High risk neuroblastoma:
Small steps towards cure. Pediatr Blood Cancer. 61:964–965. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Garaventa A, Parodi S, De Bernardi B, Dau
D, Manzitti C, Conte M, Casale F, Viscardi E, Bianchi M, D'Angelo
P, et al: Outcome of children with neuroblastoma after progression
or relapse. A retrospective study of the Italian neuroblastoma
registry. Eur J Cancer. 45:2835–2842. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Croce CM and Calin GA: miRNAs, cancer, and
stem cell division. Cell. 122:6–7. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Berindan-Neagoe I, Pdel Monroig C,
Pasculli B and Calin GA: MicroRNAome genome: A treasure for cancer
diagnosis and therapy. CA Cancer J Clin. 64:311–336. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lu J, Getz G, Miska EA, Alvarez-Saavedra
E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA,
et al: MicroRNA expression profiles classify human cancers. Nature.
435:834–838. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kawahara Y, Zinshteyn B, Sethupathy P,
Iizasa H, Hatzigeorgiou AG and Nishikura K: Redirection of
silencing targets by adenosine-to-inosine editing of miRNAs.
Science. 315:1137–1140. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Seitz H, Royo H, Bortolin ML, Lin SP,
Ferguson-Smith AC and Cavaillé J: A large imprinted microRNA gene
cluster at the mouse Dlk1-Gtl2 domain. Genome Res. 14:1741–1748.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Deng Y, Xiong Y and Liu Y: miR-376c
inhibits cervical cancer cell proliferation and invasion by
targeting BMI1. Int J Exp Pathol. 97:257–265. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Formosa A, Markert EK, Lena AM, Italiano
D, Finazzi-Agro' E, Levine AJ, Bernardini S, Garabadgiu AV, Melino
G and Candi E: MicroRNAs, miR-154, miR-299-5p, miR-376a, miR-376c,
miR-377, miR-381, miR-487b, miR-485-3p, miR-495 and miR-654-3p,
mapped to the 14q32.31 locus, regulate proliferation, apoptosis,
migration and invasion in metastatic prostate cancer cells.
Oncogene. 33:5173–5182. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang K, Jin J, Ma T and Zhai H:
miR-376c-3p regulates the proliferation, invasion, migration, cell
cycle and apoptosis of human oral squamous cancer cells by
suppressing HOXB7. Biomed Pharmacother. 91:517–525. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Iwaki J, Kikuchi K, Mizuguchi Y,
Kawahigashi Y, Yoshida H, Uchida E and Takizawa T: miR-376c
down-regulation accelerates EGF-dependent migration by targeting
GRB2 in the HuCCT1 human intrahepatic cholangiocarcinoma cell line.
PLoS One. 8:e694962013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zehavi L, Avraham R, Barzilai A, Bar-Ilan
D, Navon R, Sidi Y, Avni D and Leibowitz-Amit R: Silencing of a
large microRNA cluster on human chromosome 14q32 in melanoma:
Biological effects of mir-376a and mir-376c on insulin growth
factor 1 receptor. Mol Cancer. 11:442012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Jin Y, Peng D, Shen Y, Xu M, Liang Y, Xiao
B and Lu J: MicroRNA-376c inhibits cell proliferation and invasion
in osteosarcoma by targeting to transforming growth factor-alpha.
DNA Cell Biol. 32:302–309. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Huang Q, Wang C, Hou Z, Wang G, Lv J, Wang
H, Yang J, Zhang Z and Zhang H: Serum microRNA-376 family as
diagnostic and prognostic markers in human gliomas. Cancer Biomark.
19:137–144. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Dixon-McIver A, East P, Mein CA, Cazier
JB, Molloy G, Chaplin T, Lister Andrew T, Young BD and Debernardi
S: Distinctive patterns of microRNA expression associated with
karyotype in acute myeloid leukaemia. PLoS One. 3:e21412008.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Shiotani A, Murao T, Kimura Y, Matsumoto
H, Kamada T, Kusunoki H, Inoue K, Uedo N, Iishi H and Haruma K:
Identification of serum miRNAs as novel non-invasive biomarkers for
detection of high risk for early gastric cancer. Br J Cancer.
109:2323–2330. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ye G, Fu G, Cui S, Zhao S, Bernaudo S, Bai
Y, Ding Y, Zhang Y, Yang BB and Peng C: MicroRNA 376c enhances
ovarian cancer cell survival by targeting activin receptor-like
kinase 7: Implications for chemoresistance. J Cell Sci.
124:359–368. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Jiang W, Tian Y, Jiang S, Liu S, Zhao X
and Tian D: MicroRNA-376c suppresses non-small-cell lung cancer
cell growth and invasion by targeting LRH-1-mediated Wnt signaling
pathway. Biochem Biophys Res Commun. 473:980–986. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Arand J and Sage J: G1 cyclins protect
pluripotency. Nat Cell Biol. 19:149–150. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Rihani A, Vandesompele J, Speleman F and
Van Maerken T: Inhibition of CDK4/6 as a novel therapeutic option
for neuroblastoma. Cancer Cell Int. 15:762015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Musgrove EA, Caldon CE, Barraclough J,
Stone A and Sutherland RL: Cyclin D as a therapeutic target in
cancer. Nat Rev Cancer. 11:558–572. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Deshpande A, Pastore A, Deshpande AJ,
Zimmermann Y, Hutter G, Weinkauf M, Buske C, Hiddemann W and
Dreyling M: 3′UTR mediated regulation of the cyclin D1
proto-oncogene. Cell Cycle. 8:3592–3600. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Mitra D, Das PM, Huynh FC and Jones FE:
Jumonji/ARID1 B (JARID1B) protein promotes breast tumor cell cycle
progression through epigenetic repression of microRNA let-7e. J
Biol Chem. 286:40531–40535. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zheng L, Qi T, Yang D, Qi M, Li D, Xiang
X, Huang K and Tong Q: microRNA-9 suppresses the proliferation,
invasion and metastasis of gastric cancer cells through targeting
cyclin D1 and Ets1. PLoS One. 8:e557192013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Bonci D, Coppola V, Musumeci M, Addario A,
Giuffrida R, Memeo L, D'Urso L, Pagliuca A, Biffoni M, Labbaye C,
et al: The miR-15a-miR-16-1 cluster controls prostate cancer by
targeting multiple oncogenic activities. Nat Med. 14:1271–1277.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Trompeter HI, Abbad H, Iwaniuk KM, Hafner
M, Renwick N, Tuschl T, Schira J, Müller HW and Wernet P: MicroRNAs
miR-17, miR-20a, and miR-106b act in concert to modulate E2F
activity on cell cycle arrest during neuronal lineage
differentiation of USSC. PLoS One. 6:e161382011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Hermeking H: The miR-34 family in cancer
and apoptosis. Cell Death Differ. 17:193–199. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Elliman SJ, Howley BV, Mehta DS, Fearnhead
HO, Kemp DM and Barkley LR: Selective repression of the oncogene
cyclin D1 by the tumor suppressor miR-206 in cancers. Oncogenesis.
3:e1132014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Buechner J, Tømte E, Haug BH, Henriksen
JR, Løkke C, Flægstad T and Einvik C: Tumour-suppressor microRNAs
let-7 and mir-101 target the proto-oncogene MYCN and inhibit cell
proliferation in MYCN-amplified neuroblastoma. Br J Cancer.
105:296–303. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Roth SA, Knutsen E, Fiskaa T, Utnes P,
Bhavsar S, Hald ØH, Løkke C, Mestdagh P, Johansen SD, Flægstad T
and Einvik C: Next generation sequencing of microRNAs from isogenic
neuroblastoma cell lines isolated before and after treatment.
Cancer Lett. 372:128–136. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Thorsen SB, Obad S, Jensen NF, Stenvang J
and Kauppinen S: The therapeutic potential of microRNAs in cancer.
Cancer J. 18:275–284. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Witzel II, Koh LF and Perkins ND:
Regulation of cyclin D1 gene expression. Biochem Soc Trans.
38:217–222. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Molenaar JJ, Ebus ME, Koster J, van Sluis
P, van Noesel CJ, Versteeg R and Caron HN: Cyclin D1 and CDK4
activity contribute to the undifferentiated phenotype in
neuroblastoma. Cancer Res. 68:2599–2609. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Molenaar JJ, van Sluis P, Boon K, Versteeg
R and Caron HN: Rearrangements and increased expression of cyclin
D1 (CCND1) in neuroblastoma. Genes Chromosomes Cancer. 36:242–249.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Sun F, Fu H, Liu Q, Tie Y, Zhu J, Xing R,
Sun Z and Zheng X: Downregulation of CCND1 and CDK6 by miR-34a
induces cell cycle arrest. FEBS Lett. 582:1564–1568. 2008.
View Article : Google Scholar : PubMed/NCBI
|
